ReviewMaterials today. Bio2026
Selenium nanoparticles: Eco-friendly synthesis, biological activities and biomedical applications - A comprehensive review.
Review in Materials today. Bio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Mytilus edulis-mediated green synthesis of selenium nanoparticles with antimicrobial and molluscicidal applications.Scientific reports · 2026Article
- Neuroprotective potential of synthesized coumarin-based glycinate and heterocyclic amide derivatives: an acetylcholinesterase inhibition study.Scientific reports · 2026Article
- Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The green synthesis of nanoparticles has emerged as a promising, eco-friendly, and cost-effective alternative to conventional chemical and physical methods, offering significant biomedical potential due to their biocompatibility, stability, and multifunctionality. This review provides a comprehensive overview of recent advances in the biological synthesis of selenium nanoparticles (SeNPs) using bacteria, fungi, algae, and plants. It emphasizes the roles of various biological capping agents in modulating the physicochemical properties and therapeutic efficacy of SeNPs. The review critically examines the mechanisms underlying nanoparticle formation and stabilization, followed by in-depth discussions of their diverse biomedical applications, including antibacterial, antifungal, antiviral, anticancer, antioxidant, antidiabetic, and anti-inflammatory activities. Special attention is given to the unique ability of SeNPs to selectively target pathogenic cells while minimizing toxicity to healthy tissues, positioning them as promising candidates for nanomedicine. The synergistic effects of bioactive compounds used in the capping process further enhance their therapeutic profiles. This review aims to consolidate current knowledge on green-synthesized SeNPs, highlight the mechanisms and advantages of biogenic production routes, and explore their functional versatility across biomedical disciplines. Future directions include standardizing synthesis protocols, conducting detailed toxicological evaluations, and conducting translational research to integrate SeNPs into clinical applications. Moreover, advancing the design of SeNPs-based delivery systems and exploring their role in precision medicine and synergistic therapies will be essential for their sustainable use in next-generation therapeutics.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.